Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van Loenen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Mixed T cell receptor dimers harbor potentially harmful neoreactivityMarleen M van Loenen, Renate de Boer, Avital L Amir, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Quantification of the beta-adrenoceptor ligand S-1'-[18F]fluorocarazolol in plasma of humans, rats and sheepA van Waarde, T J Visser, H Posthumus, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
International Journal of Behavioral Medicine|March 1, 2006
Adherence to nicotine replacement patch therapy in cardiovascular patientsLouise C W Wiggers, Ellen M A Smets, Frans J Oort, et al.
Journal of Virology|November 8, 2014
Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationT W H Flinsenberg, L Spel, M Jansen, et al.
Oncoimmunology|August 27, 2024
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL productsSuzanne M Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, et al.
Journal of Personalized Medicine|September 28, 2021
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I ExpressionJosephine G M Strijker, Ronja Pscheid, Esther Drent, et al.
Frontiers in Immunology|September 25, 2020
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical StudyPeter van Balen, Inge Jedema, Marleen M van Loenen, et al.
Blood|February 18, 2010
Allo-HLA reactivity of virus-specific memory T cells is commonAvital L Amir, Lloyd J A D'Orsogna, Dave L Roelen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2011
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transferAvital L Amir, Dirk M van der Steen, Marleen M van Loenen, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Mixed T cell receptor dimers harbor potentially harmful neoreactivityMarleen M van Loenen, Renate de Boer, Avital L Amir, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Quantification of the beta-adrenoceptor ligand S-1'-[18F]fluorocarazolol in plasma of humans, rats and sheepA van Waarde, T J Visser, H Posthumus, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
International Journal of Behavioral Medicine|March 1, 2006
Adherence to nicotine replacement patch therapy in cardiovascular patientsLouise C W Wiggers, Ellen M A Smets, Frans J Oort, et al.
Journal of Virology|November 8, 2014
Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationT W H Flinsenberg, L Spel, M Jansen, et al.
Oncoimmunology|August 27, 2024
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL productsSuzanne M Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, et al.
Journal of Personalized Medicine|September 28, 2021
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I ExpressionJosephine G M Strijker, Ronja Pscheid, Esther Drent, et al.
Frontiers in Immunology|September 25, 2020
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical StudyPeter van Balen, Inge Jedema, Marleen M van Loenen, et al.
Blood|February 18, 2010
Allo-HLA reactivity of virus-specific memory T cells is commonAvital L Amir, Lloyd J A D'Orsogna, Dave L Roelen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2011
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transferAvital L Amir, Dirk M van der Steen, Marleen M van Loenen, et al.
Pageof 4